PKM and cancer: If extrapolated to cancer cells, the association of at least a proportion of total PKM2 with the plasma membrane could provide a privileged ATP supply to the PMCA; this might be particularly important in circumstances where global cytosolic ATP supply is limited, such as those where the low catalytic activity of PKM2 favours biosynthesis over glycolytic ATP production.